- Home
- ACGLN vs SVA Comparison
ACGLN vs SVA Comparison
Compare ACGLN & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACGLN
- SVA
- Stock Information
- Founded
- ACGLN N/A
- SVA N/A
- Country
- ACGLN Bermuda
- SVA
- Employees
- ACGLN 5800
- SVA 3261
- Industry
- ACGLN Property-Casualty Insurers
- SVA
- Sector
- ACGLN Finance
- SVA
- Exchange
- ACGLN Nasdaq
- SVA NYSE
- Market Cap
- ACGLN N/A
- SVA N/A
- IPO Year
- ACGLN N/A
- SVA N/A
- Fundamental
- Price
- ACGLN $18.16
- SVA $6.47
- Analyst Decision
- ACGLN
- SVA
- Analyst Count
- ACGLN 0
- SVA 0
- Target Price
- ACGLN N/A
- SVA N/A
- AVG Volume (30 Days)
- ACGLN N/A
- SVA N/A
- Earning Date
- ACGLN N/A
- SVA N/A
- Dividend Yield
- ACGLN N/A
- SVA N/A
- EPS Growth
- ACGLN N/A
- SVA N/A
- EPS
- ACGLN N/A
- SVA N/A
- Revenue
- ACGLN N/A
- SVA N/A
- Revenue This Year
- ACGLN N/A
- SVA N/A
- Revenue Next Year
- ACGLN N/A
- SVA N/A
- P/E Ratio
- ACGLN N/A
- SVA N/A
- Revenue Growth
- ACGLN N/A
- SVA N/A
- 52 Week Low
- ACGLN N/A
- SVA N/A
- 52 Week High
- ACGLN N/A
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- ACGLN 23.59
- SVA N/A
- Support Level
- ACGLN $17.56
- SVA N/A
- Resistance Level
- ACGLN $19.53
- SVA N/A
- Average True Range (ATR)
- ACGLN 0.32
- SVA 0.00
- MACD
- ACGLN -0.12
- SVA -0.41
- Stochastic Oscillator
- ACGLN 28.36
- SVA 0.00
About ACGLN Arch Capital Group Ltd.
Arch Capital Group Ltd is a Bermuda company which writes insurance and reinsurance with operations in Bermuda, the United States, Canada, Europe, Australia and United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage two operating segments: corporate and other. The insurance segment provides specialty risk solutions to client across a variety of industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.